bluebird bio Inc (BLUE)
0.3626
-0.01
(-3.64%)
USD |
NASDAQ |
Nov 14, 16:00
0.3636
0.00 (0.00%)
After-Hours: 20:00
bluebird bio Gross Profit (Annual): -4.03M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -4.03M |
| December 31, 2022 | -6.48M |
| December 31, 2021 | -35.20M |
| December 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2018 | 53.69M |
| December 31, 2017 | 33.90M |
| December 31, 2016 | 6.155M |
| December 31, 2015 | 14.08M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
-35.20M
Minimum
2021
--
Maximum
2019
-9.141M
Average
-4.03M
Median
2023
Gross Profit (Annual) Benchmarks
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 42.51M |
| Predictive Oncology Inc | 1.145M |
| Spectral AI Inc | 7.88M |
| AIM ImmunoTech Inc | 0.16M |